Objective: We performed a systematic review and meta-analysis of randomized controlled trials (RCTs) assessing the effect of programmed exercise for at least 12 weeks, in postmenopausal women on insulin sensitivity-related outcomes (ISROs), including fasting insulin, C-peptide, insulin growth factor (IGF-1) and IGF-binding protein (IGFBP-3), Homeostatic Model Assessment-Insulin Resistance (HOMA-IR), and anthropometric variables.
syndrome (MetS), sleep disturbances, and other comorbidities. [1] [2] [3] [4] [5] [6] Research has demonstrated the positive effects of exercise and physical activity on reducing menopausal symptoms. Health organizations have recommended physical activity and exercise as a means to improve the health status in terms of improvements in body composition, decreased anxiety and depression, and enhanced feelings of well-being. In addition, physical activity and regular exercise can reduce all-cause and cardiovascular mortality, fat mass accumulation, and probably cancer. [7] [8] [9] The World Health Organization recommends that adults should engage in at least 150 minutes of moderate-intensity aerobic physical activity throughout the week or engage in at least 75 minutes of vigorous-intensity aerobic physical activity throughout the week or an equivalent combination of moderate and vigorousintensity activity. 10 Everyday activities such as walking and climbing have also been shown to have health benefits and is consistent when people exercise over longer periods of time. 11 Although regular exercise may improve abdominal adiposity and metabolic status, 8 the effects of exercise on insulin resistance and sensitivity have been unclear. 12, 13 Physical sedentarism is associated with development of type 2 diabetes mellitus 14 ; however, the relationship between exercise and insulin sensitivity has not been clearly defined in postmenopausal women. The objective of this systematic review and meta-analysis was to evaluate the effect of programmed exercise of at least 12 weeks in duration on insulin sensitivity markers and/or other insulin-resistance or insulin-sensitivity algorithms in postmenopausal women.
METHODS

Data sources, searches, and inclusion criteria
A comprehensive literature search was performed using PubMed-Medline, Embase, Scopus, Web of Science, and the Cochrane Library from database inception through May 3, 2016 . Database searches were performed by one investigator (V.P.). The PubMed search strategy is available as Supplementary data (http://links.lww.com/MENO/ A244). The following predetermined inclusion criteria were used: randomized controlled trials (RCTs) in healthy postmenopausal women defined as nonpregnant, middleaged women with more than 1 year without menstrual periods not related to any particular pathology; studies evaluating the association between insulin resistance or sensitivity and a program of exercise for at least 12 weeks; controls defined as postmenopausal women who did not participate in the exercise program. The searches were not restricted by language.
Our exclusion criteria were as follows: absence of a control group; absence of data on blood insulin, nonfasting/fasting C-peptide, insulin growth factor (IGF), and IGF-binding proteins (IGFBPs), and Homeostatic Model AssessmentInsulin Resistance (HOMA-IR), the quantitative insulinsensitivity check index (QUICKI), or other insulin-resistance or insulin-sensitivity algorithms 15, 16 for each of the study groups; or unclear or no definition of type of exercise.
Prespecified outcomes
Primary outcomes of interest were circulating fasting levels of insulin, C-peptide, IGF-1, and IGFBP-3, and insulin resistance/sensitivity indexes including HOMA-IR (glucose -Â insulin/a normalizing constant) and the QUICKI (inverse of the sum of the logarithms of the fasting insulin and fasting glucose value) scores. 16 Secondary outcomes of interest were blood levels of glucose, triglycerides, total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C), and low-density lipoprotein cholesterol (LDL-C), leptin, adiponectin, sex hormone-binding globulin (SHBG); systolic blood pressure (SBP) and diastolic blood pressure (DBP); anthropometric changes (body weight, body mass index [BMI] , waist circumference, waist-to-hip and waist-to-height ratios, fat mass, percentage of body fat, visceral fat area, and lean body mass).
Study selection and data extraction
After removing duplicates and articles with no available abstract, articles were screened for eligibility on the basis of title and abstract. The list of retrieved articles was screened independently by three investigators (J.C.L., V.A.V., and J.B.N.) to choose potentially relevant articles. Disparities in the selections were discussed and resolved by consensus, and disagreements were discussed and resolved with one other investigator (F.R.P.L.). Data collection was reported following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. 17 Three investigators (J.C.L., V.A.V., and J.B.N.) independently extracted relevant data (baseline characteristics and outcome variables) from each full-text included article and data recorded onto previously designed data extraction sheets. Entries were then compared for accuracy, and units of measure were transformed and homogenized with well-established conversion factors.
Risk of bias assessment
Three investigators (J.C.L., V.A.V., and J.B.N.) independently evaluated the risk of bias from each eligible RCT using the Cochrane Collaboration tool for assessing risk of bias in RCTs. 18 All discrepancies were resolved by consensus or discussion with one other investigator (A.V.H.). The following items were evaluated: randomness of the allocation sequence (selection bias); concealment of the allocation sequence (selection bias); blinding of participants and personnel and blinding to outcome assessment (performance and detection bias, respectively); incomplete outcome data (attrition bias); selective outcome reporting (reporting bias); and any other biases. For each RCT, each item was described as having either a low risk of bias, a high risk of bias, or an unclear risk of bias. RCTs with high risk of bias for items of randomization or blinding were automatically considered as having an overall high risk of bias.
Data synthesis and statistical analysis
This systematic review and meta-analysis followed the recommendations of the PRISMA statement. 17 A random-
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effects meta-analysis was conducted to determine the effect of programmed exercise versus control group on biochemical parameters and insulin resistance or insulin sensitivity indexes. Mean differences (MDs) and their 95% confidence intervals (95% CIs) between the follow-up and baseline times were calculated for cases and controls, separately for each study. Next, MDs and 95% CIs between cases and controls were calculated for each study. A subgroup analysis by duration of exercise interventions was planned depending on availability of data. We evaluated statistical heterogeneity using the Cochrane chi-square, the I 2 statistic, and the between-study variance using the tau-square ( Tau  2 ) . 18, 19 I 2 values of 30% to 60% represented a moderate level of heterogeneity. A P value less than 0.1 for the chi-square test was defined as indicating the presence of heterogeneity; a Tau 2 greater than 1 suggests the presence of substantial statistical heterogeneity. Publication bias was explored with the funnel plot and tested with the Egger test of funnel plot asymmetry, and P less than 0.05 was considered to be statistically significant. 20 Statistical analyses were conducted using Review Manager (RevMan 5.2; Cochrane Collaboration, Oxford, UK) 21 and Comprehensive Meta-analysis (Version 2; Biostat, Englewood, NJ).
RESULTS
General characteristics of studies
Our comprehensive search identified 1,453 publications. After removing duplicates, 888 articles were screened by study titles and abstracts for relevance against prespecified inclusion/exclusion criteria. One hundred forty-two studies were identified for full-text evaluation. Fourteen additional articles were identified through references of identified articles. A total of 156 articles were selected for full-text review (Fig. 1 ). Ten articles (nine in English and one in Spanish), presenting data from seven RCTs, reported different components that define insulin resistance in postmenopausal women and were included in the meta-analysis. [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] The reasons for exclusion of the remaining 146 articles are listed in Figure 1 . Table 1 summarizes the basic characteristics of the seven RCTs (n ¼ 580 women), with sample sizes ranging from 16 to 204 women. 26, 27 Studies were published between 2005 and 2013, and were conducted in both developing 31 and developed countries. [25] [26] [27] [28] [29] 31 Mean age of participants ranged from 53.9 to 60.7 years, and mean BMI ranged from 25.2 to 30.7 kg/m 2 ( Table 1 ). All interventions consisted of three to five sessions per week of aerobic exercise [22] [23] [24] [25] [27] [28] [29] [30] [31] or yoga. 26 Controls were postmenopausal women with a sedentary lifestyle and were instructed on continuing their usual daily activity. In a few studies, controls also received recommendations on healthy lifestyle. The duration of interventions ranged from 3 to 12 months. Programmed exercise was classified as ''midterm exercise intervention'' (MTEI), corresponding to 3 to 4-month exercise duration; and ''long-term exercise intervention'' (LTEI), corresponding to 6 to 12-month exercise duration. All reported primary insulin resistance-related outcomes are displayed in Table 1 .
FIG. 1. Flow chart of study selection.
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In terms of secondary outcomes, only glucose, triglycerides, body weight, BMI, waist circumference, and percentage of body fat were reported by three or more studies in each exercise group. Total cholesterol, HDL-C, LDL-C, leptin, adiponectin, SHBG, SBP and DBP, waist-to-hip and waist-toheight ratios, fat mass, visceral fat area, and lean body mass were reported in fewer than three studies (Supplementary Figs. 1-5, http://links.lww.com/MENO/A244).
Risk of bias assessment and publication bias
One study was identified with high risk of bias and two with low risk of bias (Fig. 2) . Random sequence generation was deemed adequate in three of seven trials. Allocation concealment was adequate in two trials and inadequate in one trial. Blinding for participants and personnel, and also for outcomes assessment, was absent in all studies, but this was considered unlikely to influence any outcome. No trials had incomplete outcome data, risk of selective reporting, or any other identifiable source of bias.
Meta-analyses Primary outcome analyses
In three RCTs, MTEI was significantly associated with lower insulin levels when compared with controls (MD À6.50 pmol/ L, 95% CI À11.19, À1.82, P ¼ 0.006, I
2 ¼ 0%) (Fig. 3) . In three RCTs, MTEI was also significantly associated with lower HOMA-IR values when compared with controls (MD À0.18, 95% CI À0.34, À0.03, P ¼ 0.02, I
2 ¼ 0%). On the contrary, no effect of LTEI was found on insulin levels (MD À6.63 pmol/L, 95% CI À16.91, 3.44, P ¼ 0.19, I
2 ¼ 0%) or HOMA-IR values (MD À0.13, 95% CI À0.76, 0.50, P ¼ 0.68, I 2 ¼ 39%) in four and three RCTs, respectively. In addition, no effect of LTEI was found on IGF-1 (MD 0.66 ng/mL, 95% CI À12.09, 13.41, P ¼ 0.92, I
2 ¼ 0%) or IGFBP-3 values (MD À307.15, 95% CI À848.62, 234.33, P ¼ 0.27, I
2 ¼ 64%), and there was no effect of MTEI on IGF-1 (MD 30.98, 95% CI À41.68, 103.64, P ¼ 0.4, I
2 ¼ 87%), in two RCTs each (Fig. 3) . 2 ¼ 0%) (Fig. 4) . No effect of LTEI was found on body weight or BMI values in three studies (Fig. 4) . No effect of both MTEI and LTEI was observed on glucose (three and four RCTs, respectively) or triglyceride levels in three RCTs (Fig. 5) . In other secondary outcomes, the number of studies (two RCTs) was too small to conduct statistical analysis ( Supplementary Figs. 1-3 
Secondary outcome analyses
In three RCTs, MTEI was significantly associated with lower
DISCUSSION
This meta-analysis indicates that exercising for 3 to 4 months significantly lowers insulin levels and HOMA-IR values, BMI, waist circumference, and percentage body fat; exercising for 6 to 12 months lowers waist circumference in postmenopausal women. There was low to moderate heterogeneity of effects for all outcomes among RCTs.
Physical activity and exercise are essential to maintain muscle tone and mass, to prevent fat accumulation, to reduce risk of insulin resistance, type 2 diabetes, MetS, and visceral adiposity. Beginning in the fifth decade of life, there is a decrease in functional capacity of skeletal muscle (dynapenia) and a gradual reduction of muscle mass (sarcopenia). 32 These changes are more evident and prevalent among women. In fact, in perimenopausal and postmenopausal women, musculoskeletal symptoms are more prevalent than the typical vasomotor symptoms, and persist well after hot flashes disappear or become mild. 33 Body composition is highly labile in postmenopausal women. Longitudinal studies report that on average there is a 3.4 kg increase in fat mass, a decrease in skeletal muscle mass of 0.23 kg, and 5.7 cm gain in abdominal circumference during a 6-year menopause transition. 34 These changes may be masked by the increase in fat infiltration of muscle fibers; motor units of the muscle are substituted by adipose and connective tissue, and a deficit of muscle regeneration may also develop. [35] [36] [37] There is evidence that exercise can offset at least some of these postmenopausal changes. Exercise promotes glucose cell uptake and mitochondrial function, and increases insulin sensitivity. 38, 39 Progressive resistance exercises improve strength and physical performance, and also insulin-glucose homeostasis. 40 Our results demonstrate that other forms of popular exercise including aerobics, yoga, and calisthenics may also produce substantial improvements in insulin and glucose metabolism. It appears that exercise for 6 to 12 months EXERCISE, INSULIN SENSITIVITY, AND MENOPAUSE (1) circulating insulin levels after mid-term exercise intervention; (2) circulating insulin levels after long-term exercise intervention; (3) HOMA-IR values after mid-term exercise intervention; (4) HOMA-IR values after long-term exercise intervention; (5) circulating IGF-1 levels after mid-term exercise intervention; (6) circulating IGF-1 levels after long-term exercise intervention; (7) circulating IGFBP-3 levels after long-term exercise intervention. CI, confidence interval; d.f., degree of freedom.
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did not produce improved results on insulin levels and the HOMA-IR. This finding needs cautious interpretation. The reduction in body fat accumulation and waist circumference after 6 to 12 months of exercise in postmenopausal women reported in this meta-analysis may be important in preventing the development of insulin resistance which is an established risk factor for type 2 diabetes mellitus. 41 Presence of confounding factors in this analysis cannot be excluded. Beneficial effects of diet, lifestyle, and sleep quality in postmenopausal women, as reported in other studies, [42] [43] [44] could not be discerned in the present systematic review due to the lack of information in the included RCTs.
A recent study in late premenopausal and early postmenopausal healthy nonobese women reported that a 3-month highintensity aerobic intervention significantly reduced body weight, waist circumference, and improved body composition by increasing lean body mass and decreasing fat mass. 45 In addition, both groups of women showed improvement in their blood lipid profile, blood pressure, and plasma insulin levels. 45 The RCTs in our meta-analysis included a heterogeneous population in terms of weight (overweight and mildly obese women were included) and intensity of exercise; exercise programs varied from low to moderate intensity. This physical activity has benefits in improving insulin sensitivity without FIG. 4 . Forest plot showing association between programmed exercise and anthropometry-related secondary outcomes (from the top to the bottom): (1) BMI after mid-term exercise intervention; (2) BMI after long-term exercise intervention; (3) waist circumference after mid-term exercise intervention; (4) waist circumference after long-term exercise intervention; (5) weight after long-term exercise intervention; (6) body fat (%) after mid-term exercise intervention. BMI, body mass index; CI, confidence interval; d.f., degree of freedom; SD, standard deviation.
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associated changes in circulating glucose and lipids. The HOMA-IR was significantly reduced after 3 to 4 months of exercise, although insulin and HOMA-IR values after 6 to 12 months of exercise were similar to baseline values. It can be speculated that the temporal increase in insulin sensitivity was not sustained over the long term even when the same degree of physical activity was maintained. Our study also reported anthropometric changes after 3 to 4 months of programmed exercise, including reduction of BMI and body fat percentage after 3 to 4 months of exercise, whereas the reduction of waist circumference was found after both 3 to 4 and 6 to 12 months of programmed exercise.
The MetS comprises of a cluster of three of the following items: hypertension, low HDL-C, hypertriglyceridemia, hyperglycemia, and obesity. Although insulin sensitivity/resistance is a central part of MetS pathophysiology, it is not included in its definition. 46 In postmenopausal women, MetS is associated with significantly higher blood levels of insulin, HOMA-IR, leptin and adipsin, and lower adiponectin levels. These altered biochemical parameters have been observed in women with abdominal adiposity, regardless of fulfillment of MetS criteria. 5 However, only a few RCTs included in this meta-analysis provided information on blood pressure and biochemical markers comprising MetS, which limited us from arriving at a firm conclusion on the effects of exercise on MetS components.
Overnutrition and sedentarism increase the risk of obesity and type 2 diabetes mellitus, and the loss of insulin sensitivity usually precedes these conditions. In the skeletal muscle, insulin promotes vasodilatation and increases glucose uptake in tissues. 14, 46 The beneficial effects of exercise on metabolic and anthropometric outcomes suggests further positive downstream effects on muscle function by reducing dynapenia and sarcopenia, which may secondarily reduce sarcobesity and osteoporosis-related fracture risks. The attractiveness of low to moderate programmed exercise is that it is easy to initiate and maintain, and may be the first step towards a healthier lifestyle and more intense physical activities. To our surprise, the beneficial endocrine changes observed with exercise for 3 to 4 months were not maintained over 6 to 12 months. This might be due to paucity of available studies and data. Further large studies are needed to fully elucidate which beneficial effects are maintained over the long term.
To our knowledge, this is the first systematic review and meta-analysis of RCTs evaluating the effect of programmed exercise on insulin sensitivity in postmenopausal women. Other strengths of our review include a thorough literature search with no language restriction, and contacting authors of relevant RCTs, for additional information/data for the metaanalysis may be considered other strengths.
Our study had a few limitations. Only two of the seven included studies were assessed to have low risk of bias. We identified deficiencies in reporting random sequence generation and allocation concealment in several RCTs. A majority of the exercise programs were of moderate-intensity and may generate insufficient endocrine stimulus. Low to moderate intensity exercise may induce limited insulin and HOMA-IR changes that cannot be detected after 6 to 12 months programmed exercise. Also, motivation and intensity of exercise may have been reduced FIG. 5 . Forest plot showing association between programmed exercise and metabolic secondary outcomes (from the top to the bottom): (1) circulating glucose levels after mid-term exercise intervention; (2) circulating glucose levels after long-term exercise intervention; (3) circulating triglyceride levels after mid-term exercise intervention; (4) circulating triglyceride levels after long-term exercise intervention. CI, confidence interval; d.f., degree of freedom; SD, standard deviation.
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over time among participants in the longer-duration programs. Future research should employ objective measures to quantify physical activity to gain more accurate comparisons in larger populations. Inclusion criteria and intervention guidelines differed among the control groups across RCTs. Also, the strict inclusion and exclusion criteria and specific intervention strategies (ie, exercise program or lifestyle interventions) in the context of RCTs suggest the need for judicious interpretation and generalization of our findings to real-world settings. Finally, scarcity of studies and lack of data in available RCTs precluded us from conducting all prespecified subgroup analyses.
CONCLUSIONS
This systematic review and meta-analysis of randomized controlled trials demonstrated that a 3 to 4-month aerobic exercise intervention program is associated with a significant decrease in fasting circulating insulin levels and HOMA-IR values in postmenopausal women. Given the significant association between exercise and improved insulin sensitivity parameters, implementation of exercise programs geared towards this vulnerable population appears to be essential in the prevention of insulin resistance and the associated complications. In addition, beneficial effects on anthropometric changes seen in this study can be a basis for future studies on assessing outcomes associated with variations in body fat distribution.
